Comerica Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$455K Sell
6,516
-16,964
-72% -$1.2M 0.04% 288
2023
Q2
$1.62M Sell
23,480
-135
-0.6% -$9.61K 0.11% 171
2023
Q1
$1.75M Buy
23,615
+4,149
+21% +$348K 0.13% 161
2022
Q4
$1.81M Buy
19,466
+359
+2% +$34.6K 0.13% 157
2022
Q3
$1.82M Sell
19,107
-1,313
-6% -$130K 0.15% 145
2022
Q2
$1.89M Buy
20,420
+1,551
+8% +$151K 0.14% 146
2022
Q1
$1.91M Sell
18,869
-439
-2% -$46.1K 0.13% 151
2021
Q4
$1.99M Buy
19,308
+179
+0.9% +$16.5K 0.13% 150
2021
Q3
$1.62M Sell
19,129
-2,752
-13% -$231K 0.12% 163
2021
Q2
$1.83M Buy
21,881
+1,255
+6% +$103K 0.14% 143
2021
Q1
$1.55M Buy
20,626
+101
+0.5% +$7.36K 0.12% 159
2020
Q4
$1.4M Sell
20,525
-2,340
-10% -$152K 0.11% 157
2020
Q3
$1.33M Sell
22,865
-2,400
-9% -$149K 0.12% 153
2020
Q2
$1.64M Buy
25,265
+1,280
+5% +$80.6K 0.16% 130
2020
Q1
$1.42M Sell
23,985
-1,039
-4% -$69.4K 0.16% 131
2019
Q4
$1.86M Buy
25,024
+681
+3% +$47.8K 0.18% 135
2019
Q3
$1.53M Buy
24,343
+3,591
+17% +$213K 0.16% 141
2019
Q2
$1.13M Sell
20,752
-2,657
-11% -$143K 0.12% 166
2019
Q1
$1.26M Sell
23,409
-20,340
-46% -$1.26M 0.14% 150
2018
Q4
$2.87M Sell
43,749
-9,815
-18% -$733K 0.38% 68
2018
Q3
$4.22M Sell
53,564
-16
-0% -$1.14K 0.49% 50
2018
Q2
$3.45M Buy
53,580
+1,575
+3% +$104K 0.42% 63
2018
Q1
$3.23M Sell
52,005
-6,744
-11% -$484K 0.41% 65
2017
Q4
$4.26M Sell
58,749
-652
-1% -$47.4K 0.54% 45
2017
Q3
$4.83M Sell
59,401
-1,730
-3% -$137K 0.67% 31
2017
Q2
$4.92M Buy
61,131
+37,469
+158% +$2.96M 0.73% 24
2017
Q1
$1.86M Buy
+23,662
New +$1.89M 0.29% 106
2016
Q2
Sell
-6,313
Closed -$655K 212
2016
Q1
$655K Buy
+6,313
New +$614K 0.34% 70
2015
Q3
Sell
-5,245
Closed -$550K 210
2015
Q2
$550K Sell
5,245
-28
-0.5% -$2.86K 0.14% 172
2015
Q1
$544K Buy
5,273
+420
+9% +$42.5K 0.14% 164
2014
Q4
$467K Buy
4,853
+471
+11% +$41.5K 0.3% 69
2014
Q3
$349K Buy
+4,382
New +$345K 0.24% 99

Other funds holding CVS

Comerica Securities's CVS Position: Q3 2023 in Review

Comerica Securities reduced its CVS Health (CVS) stake by 72% in Q3 2023, selling an estimated $1.2M and leaving 6,516 shares worth $455K. The position accounts for 0.04% of the portfolio, ranked #288.

Comerica Securities first reported a position in CVS in Q3 2014 and has held it in 32 quarters since. The position peaked at $4.92M in Q2 2017. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Comerica Securities held 6,516 shares of CVS Health worth $455K as of Q3 2023.
  • Comerica Securities sold 16,964 CVS Health shares in Q3 2023, an estimated $1.2M.
  • CVS Health made up 0.04% of Comerica Securities's portfolio in Q3 2023, its #288 holding.
  • Comerica Securities first reported a position in CVS Health in Q3 2014 and has held it in 32 quarters since.
  • Comerica Securities's CVS Health position peaked at $4.92M in Q2 2017.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.